Cellebrite DI Ltd.
NASDAQ:CLBT
19.64 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 109.049 | 106.858 | 95.714 | 89.582 | 93.013 | 84.179 | 76.684 | 71.234 | 74.018 | 71.675 | 62.573 | 62.385 | 67.908 | 65.887 | 59.168 | 53.283 | 57.168 | 53.241 | 45.77 | 38.734 |
| Cost of Revenue
| 17.624 | 15.444 | 16.261 | 13.264 | 14.916 | 12.878 | 13.031 | 12.406 | 12.131 | 14.534 | 13.098 | 10.983 | 12.336 | 11.954 | 10.068 | 8.199 | 10.52 | 9.501 | 8.219 | 9.639 |
| Gross Profit
| 91.425 | 91.414 | 79.453 | 76.318 | 78.097 | 71.301 | 63.653 | 58.828 | 61.887 | 57.141 | 49.475 | 51.402 | 55.572 | 53.933 | 49.1 | 45.084 | 46.648 | 43.74 | 37.551 | 29.095 |
| Gross Profit Ratio
| 0.838 | 0.855 | 0.83 | 0.852 | 0.84 | 0.847 | 0.83 | 0.826 | 0.836 | 0.797 | 0.791 | 0.824 | 0.818 | 0.819 | 0.83 | 0.846 | 0.816 | 0.822 | 0.82 | 0.751 |
| Reseach & Development Expenses
| 25.599 | 25.926 | 23.693 | 23.197 | 21.751 | 20.451 | 21.053 | 21.131 | 19.734 | 21.635 | 19.675 | 19.576 | 18.833 | 16.427 | 15.388 | 14.893 | 14.771 | 12.899 | 13.702 | 13.005 |
| General & Administrative Expenses
| 14.575 | 13.557 | 10.953 | 11.815 | 11.753 | 10.498 | 11.232 | 9.96 | 8.81 | 11.024 | 10.507 | 10.513 | 11.194 | 20.475 | 6.982 | 9.286 | 6.773 | 6.696 | 9.14 | 7.252 |
| Selling & Marketing Expenses
| 35.524 | 32.486 | 32.32 | 32.059 | 29.594 | 26.873 | 26.745 | 27.601 | 23.669 | 25.567 | 24.892 | 23.259 | 21.239 | 20.123 | 18.509 | 16.518 | 17.763 | 15.162 | 13.044 | 15.336 |
| SG&A
| 50.099 | 46.043 | 43.273 | 43.865 | 41.347 | 37.371 | 37.977 | 37.561 | 32.479 | 36.591 | 35.399 | 33.772 | 32.433 | 40.598 | 25.491 | 25.804 | 24.536 | 21.858 | 22.184 | 22.588 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.631 | 0 | -0.05 | -0.049 | 2.273 | 0 | 0 | 0 |
| Operating Expenses
| 75.698 | 71.969 | 66.966 | 67.062 | 63.098 | 57.822 | 59.03 | 58.692 | 52.213 | 58.226 | 55.074 | 53.348 | 51.266 | 57.025 | 40.879 | 40.697 | 41.58 | 34.757 | 35.886 | 35.593 |
| Operating Income
| 15.727 | 19.445 | 12.487 | 9.256 | 14.999 | 13.479 | 4.623 | 0.136 | 9.674 | -1.085 | -5.599 | -1.946 | 4.306 | -3.092 | 8.221 | 4.387 | 5.068 | 8.983 | 1.665 | -6.498 |
| Operating Income Ratio
| 0.144 | 0.182 | 0.13 | 0.103 | 0.161 | 0.16 | 0.06 | 0.002 | 0.131 | -0.015 | -0.089 | -0.031 | 0.063 | -0.047 | 0.139 | 0.082 | 0.089 | 0.169 | 0.036 | -0.168 |
| Total Other Income Expenses Net
| 4.17 | -223.982 | -34.502 | -78.576 | -27.344 | -6.63 | -36.051 | -38.775 | -0.572 | 25.422 | 38.466 | 56.4 | 49.809 | 17.812 | 0.496 | 0.366 | 0.605 | 0.417 | 1.015 | 0.142 |
| Income Before Tax
| 19.897 | -204.537 | -22.015 | -69.329 | -12.345 | 6.849 | -31.428 | -38.639 | 9.102 | 24.337 | 32.867 | 54.454 | 54.115 | 14.72 | 8.717 | 4.753 | 5.673 | 9.4 | 2.68 | -6.356 |
| Income Before Tax Ratio
| 0.182 | -1.914 | -0.23 | -0.774 | -0.133 | 0.081 | -0.41 | -0.542 | 0.123 | 0.34 | 0.525 | 0.873 | 0.797 | 0.223 | 0.147 | 0.089 | 0.099 | 0.177 | 0.059 | -0.164 |
| Income Tax Expense
| 0.628 | 2.556 | 1.796 | 2.043 | 2.302 | 0.349 | 0.92 | 1.966 | 2.024 | -0.755 | -0.33 | -0.984 | 2.244 | 6.581 | 0.921 | 1.163 | 2.719 | 1.279 | 0.717 | 0.901 |
| Net Income
| 19.269 | -207.093 | -23.811 | -71.372 | -14.647 | 6.5 | -32.348 | -40.605 | 7.078 | 25.092 | 33.197 | 55.438 | 51.871 | 8.139 | 7.796 | 3.59 | 2.954 | 8.121 | 1.963 | -11.038 |
| Net Income Ratio
| 0.177 | -1.938 | -0.249 | -0.797 | -0.157 | 0.077 | -0.422 | -0.57 | 0.096 | 0.35 | 0.531 | 0.889 | 0.764 | 0.124 | 0.132 | 0.067 | 0.052 | 0.153 | 0.043 | -0.285 |
| EPS
| 0.083 | -0.99 | -0.12 | -0.36 | -0.075 | 0.034 | -0.17 | -0.22 | 0.038 | 0.13 | 0.17 | 0.28 | 0.28 | 0.06 | 0.044 | 0.019 | 0.016 | 0.043 | 0.011 | -0.086 |
| EPS Diluted
| 0.078 | -0.99 | -0.12 | -0.36 | -0.075 | 0.032 | -0.17 | -0.22 | 0.037 | 0.13 | 0.17 | 0.28 | 0.25 | 0.05 | 0.042 | 0.019 | 0.016 | 0.043 | 0.011 | -0.086 |
| EBITDA
| 18.456 | 22.067 | 15.063 | 11.927 | -91.045 | 15.859 | 7.192 | 2.583 | 12.194 | 1.22 | -3.342 | 0.166 | 6.12 | -0.995 | 9.919 | 5.869 | 8.449 | 10.672 | 3.171 | -5.347 |
| EBITDA Ratio
| 0.169 | 0.207 | 0.157 | 0.133 | -0.979 | 0.188 | 0.094 | 0.036 | 0.165 | 0.017 | -0.053 | 0.003 | 0.09 | -0.015 | 0.168 | 0.11 | 0.148 | 0.2 | 0.069 | -0.138 |